Document Detail


Long-Term Efficacy and Safety of Lamivudine, Entecavir, and Tenofovir for Treatment of HBV-Related Cirrhosis.
MedLine Citation:
PMID:  23063679     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND & AIMS: Data are limited on the efficacy and safety of tenofovir and entecavir when given for more than 1 year to patients with hepatitis B-related cirrhosis. We investigated the long-term safety and efficacy of these antiviral drugs in patients with chronic hepatitis B virus (HBV) infection, with compensated or decompensated cirrhosis, and compare results with those from lamivudine. METHODS: We performed a retrospective analysis of data from 227 adult patients with chronic HBV infection who were diagnosed with cirrhosis, beginning in 2005, at 18 centers throughout Turkey; 104 had decompensated cirrhosis, 197 were treatment naïve before 72 received tenofovir (followed for 21.4±9.7 months), 77 received entecavir (followed for 24.0±13.3 months), and 74 received lamivudine (followed for 36.5±24.1 months). We collected data on patient demographics and baseline characteristics. Laboratory test results, clinical outcomes, and drug-related adverse events were compared among groups. RESULTS: Levels of HBV DNA <400 copies/mL were achieved in 91.5%, 92.5%, and 77% of patients receiving tenofovir, entecavir, or lamivudine, respectively. Levels of alanine aminotransferase normalized in 86.8%, 92.1%, and 71.8% of patients that received tenofovir, entecavir, and lamivudine, respectively. Child-Turcotte-Pugh scores increased among 8.5% of patients that received tenofovir, 15.6% that received entecavir, and 27.4% that received lamivudine. Frequencies of complications from cirrhosis, including hepatic encephalopathy, variceal bleeding, hepatocellular carcinoma, and mortality were similar among groups. Lamivudine had to be changed to another drug for 32.4% of the patients. CONCLUSION: Tenofovir and entecavir are effective and safe for long-term use in patients with compensated or decompensated cirrhosis from HBV infection.
Authors:
Seyfettin Köklü; Yaşar Tuna; Murat Taner Gülşen; Mehmet Demir; Aydın Şeref Köksal; Muhammet Cem Koçkar; Cem Aygün; Sahin Coban; Kamil Ozdil; Hüseyin Ataseven; Ebru Akın; Tuğrul Pürnak; Ilhami Yüksel; Hilmi Ataseven; Mehmet Ibiş; Beytullah Yıldırım; Işılay Nadir; Metin Küçükazman; Erdem Akbal; Osman Yüksel; Omer Başar
Related Documents :
12031749 - Prophylactic ondansetron is effective in the treatment of nausea and vomiting but not o...
15700129 - An open study of methotrimeprazine in the management of nausea and vomiting in patients...
19341649 - Reevaluating resumption of oral intake after abdominoplasty.
24304349 - Treatment retention, drug use and social functioning outcomes in those receiving three ...
24944399 - Comparison of beraprost and ticlopidine in chinese patients with chronic peripheral art...
17646509 - The prolonged postoperative analgesic effect when dexamethasone is added to a nonsteroi...
15064839 - Effect of androgen deprivation therapy on bone mineral density in prostate cancer patie...
20851629 - Assessment of long-term outcomes for the stroke doc telemedicine trial.
12374539 - Treatment of chronic erosive oral lichen planus with low concentrations of topical tacr...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-9
Journal Detail:
Title:  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association     Volume:  -     ISSN:  1542-7714     ISO Abbreviation:  Clin. Gastroenterol. Hepatol.     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101160775     Medline TA:  Clin Gastroenterol Hepatol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.
Affiliation:
Hacettepe University School of Medicine, Department of Gastroenterology, Ankara, Turkey. Electronic address: gskoklu@yahoo.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Degree of Damage to the Small Bowel and Serum Antibody Titers Correlate With Clinical Presentation o...
Next Document:  Gastric antral injections of botulinum toxin delay gastric emptying but do not reduce body weight.